Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection.
Audrey DionneCathie-Kim LeSteffany PoupartJulie AutmizguineLéamarie Meloche-DumasJean TurgeonAnne FournierNagib DahdahPublished in: PloS one (2018)
Children with KD and concomitant infection are more likely to have persistent fever and elevated inflammatory markers after treatment. This association increases the likelihood of receiving a second dose of IVIG but not the risk of coronary complication. Accordingly, prospective studies to distinguish true IVIG resistance from infection induced persistent fever is warranted.